Your browser doesn't support javascript.
loading
Telemedicine with special focus on allergic diseases and asthma-Status 2022: An EAACI position paper.
Smolinska, Sylwia; Popescu, Florin-Dan; Izquierdo, Elena; Antolín-Amérigo, Darío; Price, Oliver J; Alvarez-Perea, Alberto; Eguíluz Gracia, Ibon; Papadopoulos, Nikolaos G; Pfaar, Oliver; Fassio, Filippo; Hoffmann-Sommergruber, Karin; Dramburg, Stephanie; Agache, Ioana; Jutel, Marek; Brough, Helen A; Fonseca, João A; Angier, Elizabeth; Boccabella, Cristina; Bonini, Matteo; Dunn Galvin, Audrey; Gibson, Peter G; Gawlik, Radoslaw; Hannachi, Farah; Kalayci, Ömer; Klimek, Ludger; Knibb, Rebecca; Matricardi, Paolo; Chivato, Tomás.
Afiliación
  • Smolinska S; Department of Clinical Immunology, Wroclaw Medical University, Wroclaw, Poland.
  • Popescu FD; Department of Allergology, Nicolae Malaxa Clinical Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
  • Izquierdo E; Department of Basic Medical Sciences, Facultad de Medicina, Institute of Applied Molecular Medicine Instituto de Medicina Molecular Aplicada Nemesio Díez (IMMA), Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, Madrid, Spain.
  • Antolín-Amérigo D; Servicio de Alergia, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.
  • Price OJ; School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds, UK.
  • Alvarez-Perea A; Allergy Service, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
  • Eguíluz Gracia I; Gregorio Marañón Health Research Institute, Madrid, Spain.
  • Papadopoulos NG; Allergy Department, Hospital Regional Universitario de Malaga and Allergy Research Group, Instituto de Investigacion Biomedica de Malaga (IBIMA-Plataforma BIONAND). RICORS "Inflammatory Diseases", Malaga, Spain.
  • Pfaar O; Allergy Department, 2nd Pediatric Clinic, National Kapodistrian University of Athens, Athens, Greece.
  • Fassio F; Department of Otorhinolaryngology, Head and Neck Surgery, Section of Rhinology and Allergy, University Hospital Marburg, Philipps-Universität Marburg, Marburg, Germany.
  • Hoffmann-Sommergruber K; Centro Studi Allergie, Pistoia, Italy.
  • Dramburg S; Department of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria.
  • Agache I; Department of Pediatric Respiratory Care, Immunology and Intensive Care Medicine, Charité Universitätsmedizin, Berlin, Germany.
  • Jutel M; Allergy and Clinical Immunology at Transylvania University, Brasov, Romania.
  • Brough HA; Department of Clinical Immunology, Wroclaw Medical University, Wroclaw, Poland.
  • Fonseca JA; "ALL-MED" Medical Research Institute, Wroclaw, Poland.
  • Angier E; Children's Allergy Service, Evelina Children's Hospital, Guy's and St. Thomas' Hospital, London, UK.
  • Boccabella C; Department of Women and Children's Health, School of Life Course Sciences, King's College London, London, UK.
  • Bonini M; CINTESIS@RISE, MEDCIDS, Faculty of Medicine of the University of Porto, Porto, Portugal.
  • Dunn Galvin A; Primary Care, Population Science and Medical Education, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Gibson PG; Department of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Universitario A Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Gawlik R; Department of Cardiovascular and Thoracic Sciences, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Hannachi F; Department of Clinical and Surgical Sciences, Fondazione Policlinico Universitario A. Gemelli-IRCCS, Rome, Italy.
  • Kalayci Ö; National Heart and Lung Institute (NHLI), Imperial College London, London, UK.
  • Klimek L; School of Applied Psychology, University College Cork, Cork, Ireland.
  • Knibb R; John Hunter Hospital, Hunter Medical Research Institute, University of Newcastle, Newcastle, New South Wales, Australia.
  • Matricardi P; Department of Internal Medicine, Allergology and Clinical Immunology, Medical University of Silesia, Katowice, Poland.
  • Chivato T; Immuno-Allergology Unit, Hospital Centre of Luxembourg, Luxembourg City, Luxembourg.
Allergy ; 79(4): 777-792, 2024 Apr.
Article en En | MEDLINE | ID: mdl-38041429
ABSTRACT
Efficacious, effective and efficient communication between healthcare professionals (HCP) and patients is essential to achieve a successful therapeutic alliance. Telemedicine (TM) has been used for decades but during the COVID-19 pandemic its use has become widespread. This position paper aims to describe the terminology and most important forms of TM among HCP and patients and review the existing studies on the uses of TM for asthma and allergy. Besides, the advantages and risks of TM are discussed, concluding that TM application reduces costs and time for both, HCP and patients, but cannot completely replace face-to-face visits for physical examinations and certain tests that are critical in asthma and allergy. From an ethical point of view, it is important to identify those involved in the TM process, ensure confidentiality and use communication channels that fully guarantee the security of the information. Unmet needs and directions for the future regarding implementation, data protection, privacy regulations, methodology and efficacy are described.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Asma / Telemedicina / Hipersensibilidad Límite: Humans Idioma: En Revista: Allergy Año: 2024 Tipo del documento: Article País de afiliación: Polonia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Asma / Telemedicina / Hipersensibilidad Límite: Humans Idioma: En Revista: Allergy Año: 2024 Tipo del documento: Article País de afiliación: Polonia